Senate Committee to Subpoena Pharma CEOs Over Drug Pricing

Johnson & Johnson and Merck CEOs are called to testify on why their drugs cost significantly more in the U.S. compared to other countries.

Senate Committee on Health, Education, Labor and Pensions (HELP) Chair Bernie Sanders plans to subpoena the CEOs of Johnson & Johnson and Merck to testify on drug pricing.
The CEOs have been asked to explain why their companies charge significantly higher prices for medicine in the U.S. compared to other countries.
Bristol Myers Squibb (BMS) CEO Chris Boerner and one other unnamed pharmaceutical CEO have agreed to testify before the HELP Committee.
Johnson & Johnson, Merck, and BMS manufacture some of the most expensive drugs sold in the U.S., including Januvia, Imbruvica, and Eliquis respectively.
All three companies are currently suing to halt Medicare Drug Price Negotiation under the Inflation Reduction Act.